Related Experiment Video
Updated: Aug 11, 2026
08:01
Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
AMP-activated protein kinase and type 2 diabetes
1Diabetes Division, University of Texas Health Science Center at San Antonio and the Texas Diabetes Institute, San Antonio, TX 78207, USA. Nicolas.musi@uhs-sa.com
Current Medicinal Chemistry
|March 7, 2006
Summary
AMP-activated protein kinase (AMPK) acts as a cellular fuel gauge, restoring energy balance by regulating metabolic pathways. Its activation shows promise for treating type 2 diabetes and metabolic disorders.
Area of Science:
- Biochemistry
- Metabolic Regulation
- Pharmacology
Background:
- AMP-activated protein kinase (AMPK) functions as a cellular energy sensor, activated by low ATP levels.
- AMPK modulates diverse metabolic pathways to restore cellular energy homeostasis.
- AMPK activation is observed during skeletal muscle contraction and myocardial ischemia.
Purpose of the Study:
- To elucidate the role of AMPK in metabolic regulation.
- To explore AMPK's involvement in glucose transport and fatty acid oxidation.
- To assess AMPK as a pharmacological target for metabolic disorders.
Main Methods:
- Review of recent studies on AMPK activation and its effects.
- Analysis of AMPK's role in liver metabolism.
- Investigation of AMPK's mediation of drug and adipocytokine effects.
Main Results:
- AMPK activation enhances fatty acid oxidation and reduces glucose, cholesterol, and triglyceride production in the liver.
- AMPK mediates the metabolic effects of metformin, thiazolidinediones, leptin, and adiponectin.
- In vivo activation of AMPK with AICAR improves blood glucose and lipid profiles.
Conclusions:
- AMPK is a key regulator of cellular energy metabolism.
- AMPK plays a significant role in mediating the effects of various metabolic drugs and hormones.
- AMPK represents a promising therapeutic target for type 2 diabetes and metabolic syndrome.
Related Concept Videos
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...